Track all markets on TradingView
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
Media

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth

  • November 17, 2024
  • 51 Views

A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.

read more

​ 

​A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.
read more 

Share This Post:

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.